首页|FGFR1在泛癌组织中的表达及与其预后和免疫浸润的关系

FGFR1在泛癌组织中的表达及与其预后和免疫浸润的关系

扫码查看
目的 分析成纤维母细胞生长因子受体1(FGFR1)在泛癌组织中的表达水平,并探究其与泛癌患者的预后和免疫浸润的关系.方法 通过加利福尼亚大学圣克鲁兹分校(UCSC)Xena 平台从 TCGA 数据库下载数据,分别在TCGA GTEx样本、TCGA样本和TCGA配对样本中分析FGFR1 的表达水平,采用Kaplan-Meier方法分析FGFR1 表达水平与患者预后的相关性及临床相关分析,受试者操作特征曲线(ROC)评估FGFR1 基因对泛癌的诊断价值.应用TIM-ER2.0 及TISIDB数据库分析FGFR1 表达与多种免疫细胞及免疫亚型之间的相关性.结果 FGFR1 基因在多种肿瘤中差异表达,表达的高低与不同肿瘤患者的预后密切相关;在BLCA和KIRP中,FGFR1 表达与病理分期相关.FGFR1 在多种肿瘤中差异表达,与肿瘤的免疫微环境和分子亚型相关.结论 通过对FGFR1 的泛癌分析表明,FGFR1 表达与患者预后、病理分期、免疫浸润及免疫亚型存在相关性,FGFR1 基因有望成为肿瘤有效的预后生物标志物,为临床诊疗提供帮助.
Relationship Between FGFR1 Expression and Prognosis and Immune Invasion in Pan-Cancer Tissues
Objective The expression level of fibroblast growth factor receptor 1(FGFR1)in pancarcinoma tissues was analyzed,and the relationship between FGFR1 and the prognosis and immune invasion of pancarcinoma patients was investigated.Methods FGFR1 expression levels were analyzed in TCGA GTEx samples,TCGA samples and TCGA paired samples by down-loading data from the TCGA database through the Xena platform of the University of California,Santa Cruz(UCSC).Kaplan-Meier method was used to analyze the correlation between FGFR1 expression level and patient prognosis and clinical correlation analy-sis,and receiver operating characteristic curve(ROC)was used to evaluate the diagnostic value of FGFR1 gene in pan-cancer.TIMER2.0 and TISIDB database were used to analyze the correlation between FGFR1 expression and various immune cells and immune subtypes.Results FGFR1 gene was differentially expressed in various tumors,and its expression level was closely relat-ed to the prognosis of patients with different tumors.In BLCA and KIRP,FGFR1 expression correlates with pathological stage.FG-FR1 is differentially expressed in a variety of tumors and was associated with the tumor immune microenvironment and molecular subtypes.Conclusion Pan-cancer analysis of FGFR1 shows that FGFR1 expression is correlated with patient prognosis,patholog-ical stage,immune infiltration and immune subtype.FGFR1 gene is expected to become an effective prognostic biomarker for tumors and provide help for clinical diagnosis and treatment.

Pan-cancerFGFR1BioinformaticsComprehensive prognosticationImmune infiltration

张文君、陈清江、张旭东

展开 >

453003 新乡医学院第三附属医院

453003 新乡医学院

450052 郑州大学第一附属医院

泛癌 FGFR1 生物信息学 综合预后 免疫浸润

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(12)